Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India flag India · Delayed Price · Currency is INR
230.50
-5.54 (-2.35%)
Jul 31, 2026, 3:30 PM IST

Jagsonpal Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-1,061112.15127.6110.53225.26
Short-Term Investments
--1,1751,3521,036245.31
Cash & Short-Term Investments
1,0611,0611,2871,4791,146470.57
Cash Growth
-17.57%-17.57%-12.98%29.06%143.59%-24.34%
Accounts Receivable
-171.91131.76109.51208.72155.77
Receivables
-171.91131.76109.51208.72155.77
Inventory
-146.43152149.97206.76297.42
Prepaid Expenses
--16.6216.0210.6810.62
Other Current Assets
-51.3524.24212.9573.17156.43
Total Current Assets
-1,4311,6121,9681,6461,091
Property, Plant & Equipment
-73.588.3793.02242.78225.73
Long-Term Investments
-851.11168.624733.84290.55
Goodwill
-96.9396.93--0.3
Other Intangible Assets
-682.67759.24---
Other Long-Term Assets
-31.6757.562.9727.2534.86
Total Assets
-3,1672,7832,1711,9491,642

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-115.8197.3475.96165.8185.5
Accrued Expenses
--101.9974.1988.8679.86
Current Portion of Leases
-15.7616.0713.847.54-
Current Income Taxes Payable
-5.57--0.192.33
Current Unearned Revenue
--9.112.946.12-
Other Current Liabilities
-145.8434.5414.357.22.03
Total Current Liabilities
-282.98259.04191.28275.71269.72
Long-Term Leases
-65.8976.3275.5752.47-
Long-Term Deferred Tax Liabilities
-44.4130.720.7321.6332.38
Other Long-Term Liabilities
-11.7717.049.1810.7512.56
Total Liabilities
-405.05383.1296.76360.56314.66

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-133.93132.8132.19130.99130.99
Additional Paid-In Capital
--140.56111.266
Retained Earnings
--1,9061,4601,3631,112
Comprehensive Income & Other
-2,628219.65170.788.5278.87
Shareholders' Equity
2,7622,7622,4001,8741,5891,328
Total Liabilities & Equity
-3,1672,7832,1711,9491,642

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
81.6581.6592.3989.4160.01-
Net Cash (Debt)
979.55979.551,1951,3901,086470.57
Net Cash Growth
-18.02%-18.02%-14.03%27.96%130.84%-15.07%
Net Cash Per Share
14.4414.3517.7520.9616.597.18
Filing Date Shares Outstanding
65.9570.166.466.0965.565.5
Total Common Shares Outstanding
65.9570.166.466.0965.565.5
Working Capital
-1,1481,3531,7771,370821.09
Book Value Per Share
39.4039.4036.1428.3524.2620.27
Tangible Book Value
1,9821,9821,5431,8741,5891,327
Tangible Book Value Per Share
28.2828.2823.2428.3524.2620.27
Land
----87.5987.59
Buildings
----163.8163.8
Machinery
--14.7720.3818.02329.61